Rs. Sloboda et al., OPTIMIZED LOW-DOSE RATE PELLET CONFIGURATIONS FOR INTRAVAGINAL BRACHYTHERAPY, International journal of radiation oncology, biology, physics, 26(3), 1993, pp. 499-511
Citations number
10
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: The objective was to identify configurations of low dose rate
pellet sources that optimize short treatment length brachytherapy dos
e distributions for a set of four intravaginal applicators. Methods an
d Materials: The method of simulated annealing was used. Dose rates at
calculation points on the surface of 2.0, 2.5, 3.0, and 3.5 cm diamet
er applicators along a fixed 3.0 cm treatment length were optimized fo
r Cs-137sources of strengths 0.74 and 0.63 GBq in trains having maximu
m lengths of 3.0, 3.5 and 4.0 cm. Variations in the optimization algor
ithm involving two different objective functions and different combina
tions of selectable parameters were investigated in an effort to stand
ardize the approach. Results: An objective function based on the maxim
um dose rate difference at the calculation points in conjunction with
a single parameter set proved suitable for all applicators. Optimized
solutions involving both a single configuration of sources and a combi
nation of two such configurations were successfully identified. The la
tter consistently afforded superior dose rate uniformity, particularly
for the smaller diameter applicators. A maximum source train length o
f 3.5 cm was found to provide a good compromise between attaining dose
rate uniformity along the 3.0 cm treatment length and minimizing irra
diation of adjacent normal tissues. For each applicator, an optimized
3.5 cm pellet train yielded better surface dose rate uniformity than a
corresponding optimum-length linear source. Conclusion: Pellet config
urations that optimize dose distributions for intravaginal brachythera
py applicators can be reliably identified with modest computational ef
fort using the method of simulated annealing. The method is therefore
suitable for use in routine clinical treatment planning for this site.